Medline prices IPO at $29 per share

Medline Inc. announced the pricing of its initial public offering of 216,034,482 shares of Class A common stock at $29.00 per share. The company has granted underwriters a 30-day option to purchase up to an additional 32,405,172 shares.

The shares are expected to begin trading on the Nasdaq Global Select Market on December 17, 2025, under the ticker symbol NASDAQ: MDLN. The offering is expected to close on December 18, 2025, subject to customary closing conditions.

Medline stated it intends to use proceeds from the issuance of 179,000,000 shares to repay outstanding debt under its senior secured term loan facilities, with the remainder allocated for general corporate purposes and offering expenses. Proceeds from the issuance of 37,034,482 shares and any additional shares from the underwriters' option will be used to purchase or redeem equity interests from certain pre-IPO owners.

Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities and J.P. Morgan are serving as global coordinators and lead bookrunning managers for the offering. Multiple additional firms are participating as bookrunning managers and co-managers.

A registration statement relating to the securities was filed with the Securities and Exchange Commission and declared effective on December 16, 2025, according to the company's statement.

You May Also Be Interested In